Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jacinta Jacob"'
Autor:
Jacinta Jacob, Suchita Nadkarni, Alessia Volpe, Qi Peng, Sim L. Tung, Rosalind F. Hannen, Yasmin R. Mohseni, Cristiano Scotta, Federica M. Marelli-Berg, Robert I. Lechler, Lesley A. Smyth, Gilbert O. Fruhwirth, Giovanna Lombardi
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 20, Iss , Pp 324-336 (2021)
Regulatory T cells (Tregs) are emerging as a new cell-based therapy in solid organ transplantation. Adoptive transfer of Tregs has been shown preclinically to protect from graft rejection, and the safety of Treg therapy has been demonstrated in clini
Externí odkaz:
https://doaj.org/article/dcb780cc658b4eca9c8ec6f37d4a09f0
Autor:
Jacinta Jacob, Alessia Volpe, Qi Peng, Robert I. Lechler, Lesley A. Smyth, Giovanna Lombardi, Gilbert O. Fruhwirth
Publikováno v:
Molecules, Vol 28, Iss 3, p 1482 (2023)
Regulatory T cells (Tregs) are a promising candidate cell therapy to treat autoimmune diseases and aid the longevity of transplanted solid organs. Despite increasing numbers of clinical trials using human Treg therapy, important questions pertaining
Externí odkaz:
https://doaj.org/article/c2ce8a9f7b0347a791e20018dcb780c4
Autor:
Qi Peng, Kulachelvy Ratnasothy, Dominic A. Boardman, Jacinta Jacob, Sim Lai Tung, Daniel McCluskey, Lesley A. Smyth, Robert I. Lechler, Anthony Dorling, Giovanna Lombardi
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Regulatory T cells (Tregs) are a subpopulation of T cells that maintain immunological tolerance. In inflammatory responses the function of Tregs is tightly controlled by several factors including signaling through innate receptors such as Toll like r
Externí odkaz:
https://doaj.org/article/ab830a7319954268879564c2dfcca450
Autor:
Cristiano Scottà, Federica M. Marelli-Berg, Jacinta Jacob, Alessia Volpe, Suchita Nadkarni, Giovanna Lombardi, Sim L. Tung, Gilbert O. Fruhwirth, Yasmin R. Mohseni, Rosalind F. Hannen, Qi Peng, Lesley A. Smyth, Robert I. Lechler
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 20, Iss, Pp 324-336 (2021)
Regulatory T cells (Tregs) are emerging as a new cell-based therapy in solid organ transplantation. Adoptive transfer of Tregs has been shown preclinically to protect from graft rejection, and the safety of Treg therapy has been demonstrated in clini
Autor:
Jacinta, Jacob, Suchita, Nadkarni, Alessia, Volpe, Qi, Peng, Sim L, Tung, Rosalind F, Hannen, Yasmin R, Mohseni, Cristiano, Scotta, Federica M, Marelli-Berg, Robert I, Lechler, Lesley A, Smyth, Gilbert O, Fruhwirth, Giovanna, Lombardi
Publikováno v:
Molecular Therapy. Methods & Clinical Development
Regulatory T cells (Tregs) are emerging as a new cell-based therapy in solid organ transplantation. Adoptive transfer of Tregs has been shown preclinically to protect from graft rejection, and the safety of Treg therapy has been demonstrated in clini
Autor:
Jacinta Jacob, Kulachelvy Ratnasothy, Dominic A. Boardman, Robert I. Lechler, Qi Peng, Anthony Dorling, Sim L. Tung, Giovanna Lombardi, Daniel McCluskey, Lesley A. Smyth
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Peng, Q, Ratnasothy, K, Boardman, D A, Jacob, J, Tung, S L, Mccluskey, D, Smyth, L A, Lechler, R I, Dorling, A & Lombardi, G 2019, ' Protease Activated Receptor 4 as a Novel Modulator of Regulatory T Cell Function ', Frontiers in Immunology, vol. 10, no. JUN, 1311, pp. 1-14 . https://doi.org/10.3389/fimmu.2019.01311
Frontiers in Immunology
Peng, Q, Ratnasothy, K, Boardman, D A, Jacob, J, Tung, S L, Mccluskey, D, Smyth, L A, Lechler, R I, Dorling, A & Lombardi, G 2019, ' Protease Activated Receptor 4 as a Novel Modulator of Regulatory T Cell Function ', Frontiers in Immunology, vol. 10, no. JUN, 1311, pp. 1-14 . https://doi.org/10.3389/fimmu.2019.01311
Frontiers in Immunology
Regulatory T cells (Tregs) are a subpopulation of T cells that maintain immunological tolerance. In inflammatory responses the function of Tregs is tightly controlled by several factors including signaling through innate receptors such as Toll like r
Publikováno v:
Boardman, D A, Jacob, J, Smyth, L A, Lombardi, G & Lechler, R I 2016, ' What Is Direct Allorecognition? ', Current transplantation reports, vol. 3, no. 4, pp. 275-283 . https://doi.org/10.1007/s40472-016-0115-8
Current Transplantation Reports
Current Transplantation Reports
Direct allorecognition is the process by which donor-derived major histocompatibility complex (MHC)-peptide complexes, typically presented by donor-derived ‘passenger’ dendritic cells, are recognised directly by recipient T cells. In this review,